Tag: Slate
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Deals of the Year 2025
A look back at the blockbuster transactions of 2025 as we gallop into the Year of the Horse
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Built for finance
As investment flows into infrastructure, renewables and emerging technologies, project finance continues to evolve
